What does Veritas In Silico Inc. do?
Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. The company has commercialization agreement with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. Veritas In Silico Inc. was incorporated in 2016 and is based in…
What is Veritas In Silico Inc.'s P/E and P/B ratio?
Veritas In Silico Inc. has a P/E ratio of -3.1 and a P/B ratio of 1.39.
What is Veritas In Silico Inc.'s debt-to-equity ratio?
Veritas In Silico Inc. has a debt-to-equity ratio of 0.00.
How much does Veritas In Silico Inc. owe compared with what it owns?
Veritas In Silico Inc. owes ¥0.08 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is Veritas In Silico Inc.'s Positivity rank?
Veritas In Silico Inc. is ranked #2,673 of 10,750 companies globally and #1,186 of 3,683 in Japan on PositoAI, with a Positivity Score of 22,934.
Does Veritas In Silico Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Veritas In Silico Inc..
Where can I read the latest news about Veritas In Silico Inc.?
Recent headlines about Veritas In Silico Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Veritas In Silico Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Veritas In Silico Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.